This message was sent to ##Email##. To advertise in this publication please click here

July 22, 2020

TOP NEWS

Lifestyle choices may reduce breast cancer risk regardless of genetics Medscape A "favorable" lifestyle was associated with a reduced risk of breast cancer even among women at high genetic risk for the disease in a study of more than 90,000 women, researchers reported. The findings suggest that, regardless of genetic risk, women may be able to reduce their risk of developing breast cancer by getting adequate levels of exercise; maintaining a healthy weight; and limiting or eliminating use of alcohol, oral contraceptives, and hormone replacement therapy. READ MORE

ASCT NEWS

Congratulations to our 2020 Cytotechnology Graduates! ASCT ASCT wishes you the best in your new profession! Remember to check out the ASCT Career Center, a free service that provides access to cytotechnology positions and employers. In addition to posting their resumes, job seekers can browse and view available jobs based on their criteria and save those jobs for later review if they choose. Job seekers can also create a search agent to provide email notifications of jobs that match their criteria. Employers can post jobs online, search for qualified candidates based on specific job criteria, and create an online resume agent to email qualified candidates daily. They also benefit from online reporting that provides job activity statistics. As a registered employer or job seeker you also have access to the National Healthcare Career Network (NHCN), a network of over 60 top healthcare associations and professional organizations. ASCT’s alliance with NHCN increases your reach to over 7,000 resumes and over 1,500 job postings – giving you more control over your career advancement and a one-stop-shop to find targeted and quality candidates. Click here to visit the Career Center.

UPCOMING EVENTS

Available for 6 months after subscribing Quality Assessment Center (QAC) Cell Blocks Basics Workbench YOUR PC MORE INFO Available for 6 months after subscribing Quality Assessment Center (QAC) Document Control for Cytopathology Workbench YOUR PC MORE INFO Available for 6 months after subscribing The LEAN Cytopathology Laboratory Workbench YOUR PC MORE INFO

PRODUCT SHOWCASE Efficient Non-GYN Cytology Processing The F-50 Non-Gyn Slide Processor has a liquid-based cytology system that features more cells per slide, and doesn’t need duplicate preps. The dual filtration disposable filters remove non-diagnostic material to optimize cell presentation. Cells of interest are transferred to the slide in a homogenous thin-layer cell deposit. Throughput: 50 samples/hr. LEARN MORE

INDUSTRY NEWS

American Cancer Society updates guideline for HPV vaccination Medical Xpress The American Cancer Society (ACS) has updated its guideline for HPV vaccination, adapting a 2019 update from the Federal Advisory Committee on Immunization Practices (ACIP). The ACS's update addresses three key issues: The ACS adaptation emphasizes that vaccination may be routinely offered at age 9-12; it endorses harmonization of catch-up vaccination for all individuals through age 26 while continuing to include a qualifying statement about reduced effectiveness of vaccination at older ages (i.e., young adults as compared to teens and pre-teens); and does not endorse the recommendation for shared clinical decision-making about vaccination for adults aged 27-45 years. READ MORE

HPV might cause 1 in 5 cases of prostate cancer, analysis says UPI Just over 20% of men with prostate cancer tested positive for the human papillomaviruses, or HPVs, an analysis published in the journal Infectious Agents and Cancer found. The link suggests the viruses might be among the causes of a cancer that kills an estimated 30,000 American men each year, supporting the case for universal vaccination, the researchers said. READ MORE

NIH spearheads study to test at-home screening for HPV and cervical cancer Kaiser Health News With a tiny brush, briefly swab the vagina to collect cells. Then slide the swab into a screening kit and drop it into the mail. Proponents believe a simple test like this, which can be done at home, may help the U.S. move closer to eradicating cervical cancer. The National Cancer Institute plans to launch a multisite study next year involving roughly 5,000 women to assess whether self-sampling at home is comparable to screening in the office by a clinician. READ MORE

MORE NEWS

Breast cancer patients 60% more likely to die of cancer after surviving a heart attack Technology Networks People with breast cancer are 60% more likely to die of cancer after surviving a heart attack, a new study finds.Led by researchers at NYU Grossman School of Medicine, the study shows how heart attacks, by blocking blood flow through arteries, trigger a specific, procancer immune reaction. READ MORE

FDA approves breast cancer treatment that can be administered at home by healthcare professional FDA Recently, the U.S. Food and Drug Administration approved Phesgo — a combination of pertuzumab, trastuzumab and hyaluronidase–zzxf — for injection under the skin to treat adult patients with HER2-positive breast cancer that has spread to other parts of the body, and for treatment of adult patients with early HER2-positive breast cancer. Patients should be selected based on an FDA-approved companion diagnostic test. READ MORE

ASCT Viewpoint   Connect with ASCT Dennis Hall, Director of Publishing, 469-420-2656 | Download media kit Jacqueline Hansen, Content Editor, 469-420-2636 | Contribute news American Society for Cytotechnology 1500 Sunday Drive, Suite 102 | Raleigh, NC 27607 919-861-5571 | Contact Us | www.asct.com Click here to unsubscribe. Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE SUBSCRIBE PAST ISSUES 7701 Las Colinas Ridge, Ste. 800, Irving, TX, 75063